7,8-(methylenedioxy)-14-hydroxyberbane has been researched along with oxotremorine in 3 studies
| Studies (7,8-(methylenedioxy)-14-hydroxyberbane) | Trials (7,8-(methylenedioxy)-14-hydroxyberbane) | Recent Studies (post-2010) (7,8-(methylenedioxy)-14-hydroxyberbane) | Studies (oxotremorine) | Trials (oxotremorine) | Recent Studies (post-2010) (oxotremorine) |
|---|---|---|---|---|---|
| 40 | 0 | 0 | 1,930 | 6 | 99 |
| Protein | Taxonomy | 7,8-(methylenedioxy)-14-hydroxyberbane (IC50) | oxotremorine (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.4 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 5 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 2.321 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 2.7261 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 2.7261 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 2.7261 | |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 8 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 2.7261 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 4.5012 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baranyi, M; Mike, A; Milusheva, E; Vizi, ES; Zelles, T | 1 |
| Fehér, E; Matkó, I; Vizi, ES | 1 |
| Baranyi, M; Bencsics, A; Hashim, A; Lajtha, A; Sershen, H; Vizi, ES | 1 |
3 other study(ies) available for 7,8-(methylenedioxy)-14-hydroxyberbane and oxotremorine
| Article | Year |
|---|---|
Release of acetylcholine and noradrenaline from the cholinergic and adrenergic afferents in rat hippocampal CA1, CA3 and dentate gyrus regions.
Topics: Acetylcholine; Adrenergic alpha-Antagonists; Afferent Pathways; Animals; Atropine; Berberine; Choline; Clonidine; Hippocampus; In Vitro Techniques; Luminescent Measurements; Male; Norepinephrine; Oxotremorine; Physostigmine; Pyramidal Tracts; Rats; Rats, Wistar; Tritium | 1994 |
Receptor mediated presynaptic modulation of the release of noradrenaline in human papillary muscle.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atropine; Berberine; Chromatography, High Pressure Liquid; Culture Techniques; Dopamine beta-Hydroxylase; Electric Stimulation; Feedback; Female; Heart Atria; Humans; Immunohistochemistry; Male; Middle Aged; Norepinephrine; Oxotremorine; Pancuronium; Papillary Muscles; Piperidines; Presynaptic Terminals; Receptors, Muscarinic; Sympathetic Nervous System; Tritium; Xylazine | 1994 |
Dopamine, as well as norepinephrine, is a link between noradrenergic nerve terminals and splenocytes.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Animals; Berberine; Clonidine; Desipramine; Dopamine; Dopamine Antagonists; Electric Stimulation; Male; Muscarinic Agonists; Norepinephrine; Oxotremorine; Presynaptic Terminals; Rats; Rats, Wistar; Spleen; Sulpiride; Sympathomimetics; Tritium | 1997 |